This nanodrug significantly improves the therapeutic efficacy of PD‐1 blockade, leading to robust tumor growth inhibition and prolonged survival of mice in EGFR‐mutant NSCLC models. This evidence concerns the gene EGFR and non-small cell lung carcinoma.